Ushering in a New Era of Sustainable Weight Loss with Incretin-Based Therapies

Download All
Faculty assess the metabolic adaptations in obesity, the value of sustained weight loss and related complications, and the latest evidence for incretin-based therapies for long-term weight management.
Randy J. Seeley, PhD
Jenny Tong, MD, MPH
Kristina M. Utzschneider, MD


Here’s how I dose incretins and how I address potential GI adverse events, pancreatitis, and gallstones.

Kristina M. Utzschneider, MD Released: April 12, 2021

Read my answers to healthcare professionals’ questions about starting and stopping incretins in patients needing weight loss.

Jenny Tong, MD, MPH Released: May 4, 2021

Why I think set points are key to understanding weight and weight loss.

Randy J. Seeley, PhD Released: May 4, 2021
Provided by Endocrine Society

For questions about content or obtaining CME credit, please contact the Endocrine Society at

In collaboration with Clinical Care Options
Supported by an educational grant from
Novo Nordisk Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.